© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to May
potent, selective CECR2 bromodomain inh.
cell permeable tool compound
from HTS + SBDD on ATAD2, CECR2 model
J. Med. Chem., May 28, 2020
GlaxoSmithKline, Stevenage, UK
GSK232 is a highly selective cell-penetrant inhibitor of the non-BET CECR2 bromodomain with >500-fold selectivity over BET-family bromodomains identified during a campaign to find selective inhibitors of the bromodomain…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.